메뉴 건너뛰기
The Lancet
Volumn 381, Issue 9877, 2013, Pages 1536-1537
Regorafenib for metastatic colorectal cancer
Author keywords

[No Author keywords available]
Indexed keywords

REGORAFENIB;
EID: 84877305907     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60975-7     Document Type: Letter
Times cited : (6)
References (6)
  • 1
    • 84872921660 scopus 로고    scopus 로고
    • Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): An international, multicentre, randomised, placebo-controlled, phase 3 trial
    • A Grothey, E Van Cutsem, A Sobrero et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 381 2013 303 312
    • (2013) Lancet , vol.381 , pp. 303-312
    • Grothey, A.1    Van Cutsem, E.2    Sobrero, A.3
  • 2
    • 84872892692 scopus 로고    scopus 로고
    • Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): An international, multicentre, randomised, placebo-controlled, phase 3 trial
    • GD Demetri, P Reichardt, YK Kang et al. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 381 2013 295 302
    • (2013) Lancet , vol.381 , pp. 295-302
    • Demetri, G.D.1    Reichardt, P.2    Kang, Y.K.3
  • 3
    • 84860531989 scopus 로고    scopus 로고
    • A phase i dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors
    • K Mross, A Frost, S Steinbild et al. A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors Clin Cancer Res 18 2012 2658 2667
    • (2012) Clin Cancer Res , vol.18 , pp. 2658-2667
    • Mross, K.1    Frost, A.2    Steinbild, S.3
  • 4
    • 84861459479 scopus 로고    scopus 로고
    • Regorafenib (BAY 73-4506) in advanced colorectal cancer: A phase i study
    • D Strumberg, ME Scheulen, B Schultheis et al. Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study Br J Cancer 106 2012 1722 1727
    • (2012) Br J Cancer , vol.106 , pp. 1722-1727
    • Strumberg, D.1    Scheulen, M.E.2    Schultheis, B.3
  • 5
    • 84863698793 scopus 로고    scopus 로고
    • Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: A multicenter phase II trial
    • S George, Q Wang, MC Heinrich et al. Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial J Clin Oncol 30 2012 2401 2407
    • (2012) J Clin Oncol , vol.30 , pp. 2401-2407
    • George, S.1    Wang, Q.2    Heinrich, M.C.3
  • 6
    • 34249085905 scopus 로고    scopus 로고
    • Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
    • DOI 10.1200/JCO.2006.07.3049
    • H Choi, C Charnsangavej, SC Faria et al. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria J Clin Oncol 25 2007 1753 1759 (Pubitemid 46797957)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.13 , pp. 1753-1759
    • Choi, H.1    Charnsangavej, C.2    Faria, S.C.3    Macapinlac, H.A.4    Burgess, M.A.5    Patel, S.R.6    Chen, L.L.7    Podoloff, D.A.8    Benjamin, R.S.9

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.